Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(1e)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1h-pyrazol-4-yl)-2,3-dihydro-1h-inden-1-one oxime
- Development stage
- Unknown
- Lead developer
- Genentech
- Modality
- Small Molecules
01
Overview
(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime is a small molecule experimental compound. It belongs to the phenylpyrazole class and contains an indane moiety. The compound targets serine/threonine-protein kinase B-Raf (BRAF), which is involved in cell signaling pathways that regulate cell growth and proliferation. There are no approved indications or clinical trials reported for this drug as of current data[2][4]. No specific developer or manufacturer has been identified.
- Other names
- (1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-H-inden-one oximeCHEMBL526479CHEMBL-526479CHEMBL 526479SCHEMBL4133601SCHEMBL-4133601SCHEMBL 4133601BDBM50006650BDBM-50006650BDBM 50006650DB08553DB-08553DB 08553N-Hydroxy-N-[5-[1-(piperidinyl)-3-(pyridinyl)pyrazolyl]-2,3-dihydroindenylidene]amine (IUPAC-like)N-Hydroxy-N-[5-[1-(piperidinyl)-3-(pyridinyl)pyrazolyl]-2,3-dihydroindenylidene]amine[ACD/IUPAC Name]N-Hydroxy-N-[5-[l(piperidinyl)-3-(pyridinyl)pyrazolyl]-2,3-dihydroindenylidene]amine[French][ACD/IUPAC Name]N-Hydroxy-N-[5-[l(piperidinyl)-(pyridinyl) pyrazole]-indanylidenelhydroxlamine
02
Targets
Beyond the preview
Go deeper on (1e)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1h-pyrazol-4-yl)-2,3-dihydro-1h-inden-1-one oxime.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (1e)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1h-pyrazol-4-yl)-2,3-dihydro-1h-inden-1-one oxime.